Back to Authors

Shieb, Mohamad

0009-0009-7008-3685

Mayo Clinic

Department of Pediatric and Adolescent Medicine, Division of Pediatric Infectious Diseases, Mayo Clinic, Rochester, MN, USA.

Citations 1

Real-World Experience of Concomitant Isavuconazole and Vincristine Administration

Journal of the Pediatric Infectious Diseases Society | November 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/jpids/piag116 | PMID 43007301

Three pediatric oncology patients received isavuconazole concurrently with vincristine across 15 days to approximately 23 months, spanning 32 vincristine doses. No severe adverse effect including neurotoxicity or paralytic ileus was attributed to the combination.